microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway-Reference-Cited by-同舟云学术

microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway

Published:2018-10-30 Issue:1 Volume:76 Page:17-23
ISSN:0967-4845
Container-title:British Journal of Biomedical Science
language:en
Short-container-title:British Journal of Biomedical Science

Author:

Wang C¹,Li S¹,Xu J²,Niu W³,Li S¹

Affiliation:

1. Respiratory Medicine Department, The First Affiliated Hospital of JIAMUSI University, Jia Mu Si, PR China

2. Intensive Care Unit, The First Affiliated Hospital of JIAMUSI University, Jia Mu Si, PR China

3. Urinary Surgery, The First Affiliated Hospital of JIAMUSI University, Jia Mu Si, PR China

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Biochemistry (medical),Microbiology (medical),Clinical Biochemistry,Immunology,Microbiology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09674845.2018.1520066

Reference33 articles.

1. Cancer statistics, 2013

2. Global cancer statistics, 2012

3. Lung Cancer

4. Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer

5. Maintenance Therapies for Non-Small Cell Lung Cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The roles of E2F7 in cancer: Current knowledge and future prospects;Heliyon;2024-07

2. Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress;Cells;2023-09-18

3. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR‐379‐5p;Thoracic Cancer;2023-06-05

4. Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma;Heliyon;2022-10

5. Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer;Pharmaceutics;2022-09-24